No, they are not equivalent doses
Lori Sussel, PhD, associate vice chancellor for basic science at CU Anschutz and research director at the Barbara Davis Center for Diabetes, shared the history and mechanisms of GLP-1s
The second hormone, GIP, is believed to complement these effects by improving how the body breaks down sugar and fat
Research involving 65 healthy adults showed CJC-1295 therapy for 90 days resulted in significant increases in lean body mass (average 4.1kg), decreased body fat percentage (average 2.8% reduction), and improved exercise capacity
The gut-thyroid axis and why it matters Research has revealed a bidirectional relationship between intestinal health and thyroid function that researchers call the gut-thyroid axis
5.8 Diabetic Retinopathy Complications in Patients with Type 2 Diabetes In a 2-year trial with semaglutide 0.5 mg and 1 mg once-weekly injection in adult patients with type 2 diabetes and high CV risk, diabetic retinopathy complications (which was a 4-component adjudicated endpoint) occurred in patients treated with semaglutide injection (3%) compared to placebo (1.8%)